IL-11R binding proteins
US9340618B2 · kind B2 · utility
20Cited by
1References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 6, 2014 |
| Grant date | May 17, 2016 |
| Priority date | — |
| Expiry date | Apr 14, 2034 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/7155
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides proteins comprising antigen binding sites of antibodies that bind to interleukin-11 (IL-11) receptor alpha (IL-11Rα) and uses thereof, e.g., in therapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.